doi:10.1016/j.endmts.2020.100059 97
Clinical Results and Weight Loss Data Retatrutide has produced some of the most impressive weight loss data seen to date: 11.5% to 16.8% weight loss in type 2 diabetes trials Up to 24% weight loss in obesity studies at 48 weeks Average loss of over 36 pounds in 40 weeks at higher doses In certain populations, including individuals with obesity and joint issues, weight loss exceeded 70 pounds over the course of a year
If youve been curious about GLP-1s but hesitant about injections, here is what you need to know about the new oral option
J., Christensen, B., Mller, N., Gillum, M
Evidence shows that GLP-1 agonists can be safely used alongside blood pressure medications and may produce modest reductions in systolic blood pressure
Most patients begin seeing noticeable changes in appetite, energy levels, and weight loss within weeks